Covered recipient · General Payments record
STANLEY E WAINTRAUB
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$4,454.31
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $103.46 | 6 |
| Education | $88.09 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $70.00 | 1 |
| Gilead Sciences, Inc. | $53.00 | 3 |
| Biocon Biologics Inc | $19.81 | 1 |
| Merck Sharp & Dohme Corporation | $18.09 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.89 | 1 |
| Acerta Pharma LLC | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.76 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105735121 | CMS |
| Biocon Biologics Inc | $19.81 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154784386 | CMS |
| Daiichi Sankyo Inc. | $70.00 | 07/24/2024 | Education | Undisputed | 01/23/2026 | 1089495838 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.89 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101423326 | CMS |
| Gilead Sciences, Inc. | $20.71 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133829129 | CMS |
| Gilead Sciences, Inc. | $13.36 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133829131 | CMS |
| Gilead Sciences, Inc. | $18.93 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133829133 | CMS |
| Merck Sharp & Dohme LLC | $18.09 | 02/12/2024 | Education | Undisputed | 01/23/2026 | 1141873951 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.